Positive I-123-MIBG-scintigraphy in osteosarcoma.
I-123-MIBG scintigraphy has become a standard imaging technique in the detection of neuroendocrine or neurocrest derived tumors, especially neuroblastoma and pheochromocytoma. We report on a positive I-123-MIBG uptake in a pediatric osteosarcoma patient and demonstrate, that unusual results still occur with this established imaging method.
von der Hardt
K
K
Department of Pediatrics, University of Erlangen-Nürnberg, Germany.
Bair
H J
HJ
Kirchner
T
T
Feistel
H
H
Beck
J
J
D019797:3-Iodobenzylguanidine; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D004164:Diphosphonates; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D009362:Neoplasm Metastasis; D015609:Organotechnetium Compounds; D012516:Osteosarcoma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
D004164:Diphosphonates; D007457:Iodine Radioisotopes; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C033905:technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid; D019797:3-Iodobenzylguanidine